Founded December 2016
Stage Technology development
Investor Trendlines Incubators Israel
CEO Kobby Greenberg
Seger Surgical Solutions CEO Kobby Greenberg in the company booth at SAGES, Baltimore, Maryland, 3-6 April 2019.
Seger is developing Lap IA™, a laparoscopic bowel closure device to easily and quickly close and staple the common opening inside the body (intracorporeal) during anastomosis procedures. With Lap IA, surgeons can quickly and accurately align the edges of the bowel opening to easily close and staple the common opening.
The device works with a standard 12 millimeter trocar.
With Seger Surgical’s Lap IA closure device, surgeons can perform bowel anastomosis in a fully laparoscopic procedure for improved clinical results, fewer complications, and reduced healthcare costs.
The Seger system allows surgeons to perform bowel resection in a fully laparoscopic procedure for improved clinical results, fewer complications, and reduced health care costs.
15+ years’ experience in medical device industry; previous positions include CEO Cleanoscope, VP R&D Niti Surgical, mechanical design consultant for KG Holdings
Internationally recognized pioneer and key opinion leader in the laparoscopic surgery field; developed techniques now considered standard of practice; founder, Laparoscopic Surgery Division, Mount Sinai Hospital, NYC; secretary of SAGES Foundation; past VP of SAGES; President of the International Federation of Surgical Endoscopic Societies (IFSES)
Founder and CEO, Med-Tech Consultant Partners; years of experience in specialty medical devices, IP, regulatory, reimbursement; founder and former CEO multimillion-dollar specialty medical distribution company (later acquired)
Chief, Department of Surgery B, Carmel Medical Center, Israel; responsible for preclinical and clinical trials
Seoul National University Bundang Hospital, Korea
Hospital Clinic University of Barcelona, Spain
IRCAD, Rio de Janeiro, Brazil
Osaka Medical College, Japan
University of California, Irvine, United States
Florida International University
Bowel resection surgery involves removing all or part of the bowel (the intestine). Often, bowel resection is the result of colon cancer or gastric bypass surgery. Laparoscopic surgery is preferred clinically; yet, few procedures are performed 100% laparoscopically.
After resection is performed, the common opening of the two sections (of bowel) must be securely closed. Suturing the common opening by hand in a laparoscopic procedure is extremely complex and is only performed in 10% of cases. So, surgeons often perform anastomosis – connecting the two sections of bowel — outside the body (extracorporeal). The resected bowel is lifted and removed through an incision, the common bowel openings are stapled closed, the bowel is returned to its place in the body, and then the laparoscopic incision is closed.
The result of extracorporeal anastomosis: increased hospitalization costs due to increased post-operative complications and longer hospital stays.
According to Millenium Research Group, U.S. Market for Laparoscopic Devices 2013, the number of bowel resections is expected to exceed 980,000 in the United States and E.U. by 2020, with an annual growth of 10%, representing a $600 million market.
